122 related articles for article (PubMed ID: 21549736)
21. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers.
Beletsi A; Panagi Z; Avgoustakis K
Int J Pharm; 2005 Jul; 298(1):233-41. PubMed ID: 15936907
[TBL] [Abstract][Full Text] [Related]
22. Strategic formulation of apigenin-loaded PLGA nanoparticles for intracellular trafficking, DNA targeting and improved therapeutic effects in skin melanoma in vitro.
Das S; Das J; Samadder A; Paul A; Khuda-Bukhsh AR
Toxicol Lett; 2013 Nov; 223(2):124-38. PubMed ID: 24070738
[TBL] [Abstract][Full Text] [Related]
23. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
24. Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer.
Sankar R; Ravikumar V
Biomed Pharmacother; 2014 Sep; 68(7):865-71. PubMed ID: 25107842
[TBL] [Abstract][Full Text] [Related]
25. Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.
Moreno D; Zalba S; Navarro I; Tros de Ilarduya C; Garrido MJ
Eur J Pharm Biopharm; 2010 Feb; 74(2):265-74. PubMed ID: 19883755
[TBL] [Abstract][Full Text] [Related]
26. Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles.
Zhang W; Gao J; Zhu Q; Zhang M; Ding X; Wang X; Hou X; Fan W; Ding B; Wu X; Wang X; Gao S
Int J Pharm; 2010 Dec; 402(1-2):205-12. PubMed ID: 20932886
[TBL] [Abstract][Full Text] [Related]
27. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
Derakhshandeh K; Erfan M; Dadashzadeh S
Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
[TBL] [Abstract][Full Text] [Related]
28. Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier.
Kulkarni SA; Feng SS
Nanomedicine (Lond); 2011 Feb; 6(2):377-94. PubMed ID: 21385139
[TBL] [Abstract][Full Text] [Related]
29. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
Nie H; Wang CH
J Control Release; 2007 Jul; 120(1-2):111-21. PubMed ID: 17512077
[TBL] [Abstract][Full Text] [Related]
30. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
Kim BS; Kim CS; Lee KM
Arch Pharm Res; 2008 Aug; 31(8):1050-4. PubMed ID: 18787796
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma.
Lee JS; An TK; Chae GS; Jeong JK; Cho SH; Lee HB; Khang G
Eur J Pharm Biopharm; 2005 Jan; 59(1):169-75. PubMed ID: 15567315
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of PLGA-loaded apigenin nanoparticles in Benzo[a]pyrene and ultraviolet-B induced skin cancer of mice: mitochondria mediated apoptotic signalling cascades.
Das S; Das J; Samadder A; Paul A; Khuda-Bukhsh AR
Food Chem Toxicol; 2013 Dec; 62():670-80. PubMed ID: 24120900
[TBL] [Abstract][Full Text] [Related]
33. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
34. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
Oster CG; Kim N; Grode L; Barbu-Tudoran L; Schaper AK; Kaufmann SH; Kissel T
J Control Release; 2005 May; 104(2):359-77. PubMed ID: 15907586
[TBL] [Abstract][Full Text] [Related]
35. Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-D,L-lactide-co-glycolide (PLGA) nanoparticles.
Nguyen HT; Tran TH; Kim JO; Yong CS; Nguyen CN
Arch Pharm Res; 2015; 38(5):716-24. PubMed ID: 24968925
[TBL] [Abstract][Full Text] [Related]
36. Experimental design and multivariate analysis for optimizing poly(D,L-lactide-co-glycolide) (PLGA) nanoparticle synthesis using molecular micelles.
Ganea GM; Sabliov CM; Ishola AO; Fakayode SO; Warner IM
J Nanosci Nanotechnol; 2008 Jan; 8(1):280-92. PubMed ID: 18468072
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of a novel class of coumarin derivatives.
Li H; Wang X; Xu G; Zeng L; Cheng K; Gao P; Sun Q; Liao W; Zhang J
Bioorg Med Chem Lett; 2014 Nov; 24(22):5274-8. PubMed ID: 25304898
[TBL] [Abstract][Full Text] [Related]
38. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone.
Teixeira M; Alonso MJ; Pinto MM; Barbosa CM
Eur J Pharm Biopharm; 2005 Apr; 59(3):491-500. PubMed ID: 15760730
[TBL] [Abstract][Full Text] [Related]
39. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo.
Kang BK; Chon SK; Kim SH; Jeong SY; Kim MS; Cho SH; Lee HB; Khang G
Int J Pharm; 2004 Nov; 286(1-2):147-56. PubMed ID: 15501011
[TBL] [Abstract][Full Text] [Related]
40. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]